TGI.

The Division of Translational Gastrointestinal Immunology (TGI) aims to bring together complimentary aspects of immunology and immunotherapy in gastrointestinal cancers in order to elucidate the mechanisms at play over the course of tumour development. Our goal is to develop novel therapeutic approaches in immune oncology, particularly in aggressive GI cancers, which currently face a rising incidence and poor prognosis.